Basic Concept of CSR

President, Representative Director, and CEO Gyo Sagara

Since its establishment in 1717, ONO has resolutely pushed forward in the pharmaceutical industry up to the present day and has built a history that spans almost 300 years. Upholding the corporate philosophy “Dedicated to Man’s Fight Against Disease and Pain”, we make united efforts to create innovative drugs that are globally competitive and to become a research-based international pharmaceutical company focusing on specific fields.
We will continue to single-mindedly pursue the development of drugs that truly benefit patients and raise our social value.

We also always engage with the community seriously and with sincerity. To this end, we work to further strengthen compliance to ensure that we always act in accordance with high ethical values, as well as to achieve strict compliance with laws and regulations, and take action in six priority areas that we have stipulated in light of the ONO PHARMACEUTICAL Codes of Conduct and the 7 core subjects contained in ISO 26000. The first of these priority areas is Corporate Governance, which forms the foundation for the five remaining areas of Innovative Pharmaceutical Products, Human Resources and Human Rights, The Environment, Fair Operating Practices, and Society. We will continue to fulfill our social responsibility to stakeholders by promoting activities related to these priority areas.